Eurobio Scientific announces that it has been notified that EchiumBio Holding BV, the holding company of Wietse Mulder, CEO of GenDx, a company acquired by the Group last October, has reached a 2% stake in the company's capital.

EchiumBio has exceeded the statutory threshold of 2% via purchases of shares on the market, and held 230,956 Eurobio Scientific shares as of February 3, 2023.

' The acquisition of GenDx was made entirely in cash, and the fact that Wietse has joined our capital after only a few months is a very positive signal. says Denis Fortier, CEO of Eurobio Scientific. We were delighted to welcome him to our management team, and it's a great pleasure to have him on board as a partner. It's a strong vote of confidence in our joint project. '

Eurobio Scientific's Board of Directors will recommend the appointment of Wietse Mulder as a director at the next Annual General Meeting.

Copyright (c) 2023 CercleFinance.com. All rights reserved.